HopeStage
Back to all studies
CompletedNCT01715519

Vilazodone for PTSD and Depression Symptoms

About this title

Vilazodone for the Treatment of Posttraumatic Stress Disorder

Read the official source — NCT01715519
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
Long Beach and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2012
Recruitment status
Completed
Enrollment listed in the registry
59
Sponsor
Southern California Institute for Research and Education
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT01715519
Official title
Show the full official title

A Double-blind, Placebo-controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Long Beach · Omaha

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Southern California Institute for Research and Education, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Treatment (Viibryd).

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies